Alzheimer's soluble amyloid beta protein is secreted by HEPG2 cells as an apolipoprotein

Cell Biology International

Volumn 21, Issue 5, 1997, Pages 265-271

  Koudinov, Alexei R ^a   Koudinova, Natalia V ^a  

^a PEOPLES FRIENDSHIP UNIVERSITY OF RUSSIA   (Russian Federation)

Author keywords

Alzheimer's disease; Apolipoprotein; Down's syndrome; Hepatoma; Protein synthesis; Soluble amyloid beta protein

Indexed keywords

AMYLOID BETA PROTEIN; APOLIPOPROTEIN; APOLIPOPROTEIN A1; CHOLESTEROL ESTER; LIPOPROTEIN; PHOSPHOLIPID; PREALBUMIN; TRIACYLGLYCEROL;

ALZHEIMER DISEASE; ARTICLE; CELL STRAIN HEPG2; COMPLEX FORMATION; CONTROLLED STUDY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; IMMUNOREACTIVITY; PROTEIN SECRETION; THIN LAYER CHROMATOGRAPHY;

EID: 0031148272     PISSN: 10656995     EISSN: None     Source Type: Journal    
DOI: 10.1006/cbir.1996.0126     Document Type: Article

References (39)

1. Banerjee D. Studies of nascent lipoproteins in isolated hepatic microsomes and Golgi cell fractions. Methods in Enzymology. 1986;Academic Press, New York.
2. Berezov T, Korovkin B. Chemistry and metabolism of lipids. Biochemistry. 1992;Mir Publishers, Moscow.
3. Bons N, Mestre N, Ritchie K, Petter A, Podlisny M, Selkoe D. Identification of amyloid beta protein in the brain of the small, short-lived lemurian primate Microcebus murinus. Neurobiol Aging. 15:1994;215-220.
4. Burkey B, Stuart W, Harmony J. Hepatic apoJ is secreted as a lipoprotein. J Lipid Res. 33:1992;1517-1526.
5. Busciglio J, Gabuzda DH, Matsudaira P, Yankner BA. Generation of β-amyloid in the secretory pathway in neuronal and non-neuronal cells. Proc Natl Acad Sci (U.S.A.). 90:1993;2092-2096.
6. Cai X-D, Golbe T, Younkin S. Release of excess amyloid beta protein from a mutant amyloid beta protein precursor. Science. 259:1993;514-516.
7. Caporaso G, Gandy S, Buxbaum J, Greengard P. Chloroquine inhibits intracellular degradation but not secretion of Alzheimer's β/A4 amyloid precursor protein. Proc Natl Acad Sci U.S.A. 89:1992;10,075-10,078.
8. Cheung M, Albers J. Characterization of lipoprotein particles isolated by immunoaffinity chromatography. Particles containing A-I and A-II and particles containing A-I and no A-II. J Biol Chem. 259:1984;12,201-12,209.
9. Cheung M, Lum K, Brouilette C, Bisgaier C. Characterization of ApoA1-containing lipoprotein subpopulations secreted by HepG2 cells. J Lipid Res. 30:1989;1429-1436.
10. Choi N, Tobe T, Hara K, Yoshiba H, Tomita M. Sandwich ELISA assay for quantitative measurement of SP-40, 40 in seminal plasma and serum. J Immunol Methods. 131:1990;159-163.
11. Citron M, Vigo-Pelfrey C, Teplow D, Miller C, Schenk D, Johnston J, Winblad B, Venizelos N, Lannfelt L, Selkoe D. Excessive production of amyloid beta-protein by peripheral cells of symptomatic and presymptomatic patients carrying the Swedish familial Alzheimer disease mutation. Proc Natl Acad Sci U.S.A. 91:1994;11,993-11,997.
12. Davis R, Engelhorn S, Weinstein D, Steinberg D. Very low density lipoprotein secretion by cultured rat hepatocytes: inhibition by albumin and other macromolecules. J Biol Chem. 255:1980;2039-2045.
13. Dergunov A, Shuvaev V, Yanushevskaya E. Super-molecular organization of apolipoprotein E in solution. Biokhimiya. 56:1991;1312-1321.
14. Ghiso J, Matsubara E, Koudinov A, Choi-Miura NH, Tomita M, Wisniewski T, Frangione B. The cerebrospinal-fluid soluble form of Alzheimer's amyloid beta is complexed to SP-40, 40 (apolipoprotein J), an inhibitor of the complement membrane-attack complex. Biochem J. 293:1993;27-30.
15. Ginsberg L, Atack J, Rapoport S, Gershfeld N. Evidence for a membrane lipid defect in Alzheimer disease. Mol Chem Neuropathol. 19:1993;37-46.
16. Golabak A, Marques M, Lalowski M, Wisniewski T. Amyloid β binding proteins in vitro and in normal human cerebrospinal fluid. Neurosci Lett. 191:1995;79-82.
17. Haass C, Schlossmacher M, Hung A, Vigo-Pelfry C, Mellon A, Ostaszewski B, Lieberburg I, Koo E, Schenk D, Teplow D, Selkoe D. Amyloid β-peptide is produced by cultured cells during normal metabolism. Nature. 359:1992;322-325.
18. Javitt N. HepG2 cells as a resource for metabolic studies: lipoprotein, cholesterol, and bile acids. FASEB J. 4:1990;161-168.
19. Kang J, Lemaire H, Unterbeck A, Salbaum J, Masters C, Grzeschik KH, Malthaup G, Beyreuther K, Muller-Hill B. The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor. Nature. 325:1987;733-736.
20. Kim K, Miller D, Sapienza V, Chen C, Bai C, Grundke-Iqbal I, Currie J, Wisniewski H. Production and characterization of monoclonal antibodies reactive to synthetic cerebrovascular amyloid peptide. Neurosci Res Commun. 2:1988;121-130.
21. Kingston B, Castro M, Anderson S. In vitro stimulation of tissue-type plasminogen activator by Alzheimer's amyloid β-peptide analogues. Nature Med. 1:1995;138-142.
22. Klimov A, Nikulcheva N. Apolipoproteins. Lipids, Lipoproteins and Atherosclerosis. 1994;St Petersburg, Piter.
23. Koudinov A, Matsubara E, Frangione B, Ghiso J. The soluble form of Alzheimer's amyloid beta protein is complexed to high density lipoprotein 3 and very high density lipoprotein in normal human plasma. Biochem Biophys Res Commun. 205:1994;1164-1171.
24. Koudinov A, Koudinova N, Kumar A. Is amyloid beta an apolipoprotein? Neuroscience Meeting Abstract book. 1995;New York University Medical Center, New York.
25. Koudinov A, Koudinova N, Kumar A, Beavis R, Ghiso J. Biochemical characterization of Alzheimer's soluble amyloid beta protein in human cerebrospinal fluid: association with high density lipoproteins. Biochem Biophys Res Commun. 223:1996a;592-597.
26. Koudinov A, Koudinova N, Berezov T. Alzheimer's peptides Aβ1-40 and Aβ1-28 inhibit the plasma cholesterol esterification rate. Biochem Mol Biol Int. 38:1996b;747-752.
27. Matsubara E, Soto C, Governale S, Frangione B, Ghiso J. Apolipoprotein J and Alzheimer's amyloid β solubility. Biochem J. 316:1996;671-679.
28. Motter R, VigoPelfrey C, Kholodenko D, Barbour R, Johnson-Wood B, Galasko D, Chang L, Miller B, Clark C, Green R, Olson D, Southwick P, Wolfert R, Munroe B, Lieberburg I, Seubert P, Schenk D. Reduction of β-amyloid peptide 42 in the cerebrospinal fluid of patients with Alzheimer's disease. Ann Neurol. 38:1995;643-648.
29. Palmert M, Golde T, Cohen M, Kovacs D, Tanzi R, Gusella J, Usiak M, Younkin L, Younkin SG. Amyloid protein precursor messenger RNAs: differential expression in Alzheimer's disease. Science. 241:1988;1080-1084.
30. Podlisny M, Tolan D, Selkoe DJ. Homology of the amyloid beta protein precursor in monkey and human sup-ports a primate model for beta amyloidosis in Alzheimer's disease. Am J Pathol. 138:1991;1423-1435.
31. Rosen D, Martin-Morris L, Luo L, White K. Drosophila gene encoding a protein resembling the human beta-amyloid precursor protein. Proc Natl Acad Sci U.S.A. 86:1989;2478-2482.
32. Selkoe D. Physiological production of the β-amyloid protein and the mechanism of Alzheimer's disease. Trends Neurosci. 16:1993;403-409.
33. Selkoe D. Alzheimer's disease: a central role for amyloid. J Neuropath Exp Neurol. 53:1994a;438-447.
34. Selkoe D. Cell biology of the amyloid β-protein precursor and the mechanism of Alzheimer's disease. Annu Rev Cell Biol. 10:1994b;373-403.
35. Seubert P, Vigo-Pelfrey C, Esch F, Lee M, Dovey H, Davis D, Sinha S, Schlossmacher M, Whaley J, Swindlehurst C, McCormack R, Wolfert R, Selkoe D, Lieberburg I, Schenk D. Isolation and quantification of soluble Alzheimer's β-peptide from biological fluids. Nature. 359:1992;325-327.
36. Shoji M, Golde T, Ghiso J, Cheung T, Estus S, Shaffer L, Cai X-D, McKay D, Tintner R, Frangione B, Youngkin S. Production of the Alzheimer amyloid β protein by normal proteolytic processing. Science. 258:1992;126-129.
37. Smith R, Higuchi D, Broze GJ Jr. Platelet coagulation factor XIa-inhibitor, a form of Alzheimer amyloid precursor protein. Science. 248:1990;1126-1128.
38. Tabaton M, Nunzi M, Xue R, Usiak M, Autilio-Gambetti L, Gambetti P. Soluble amyloid β-protein is a marker of Alzheimer amyloid in brain but not in cerebrospinal fluid. Biochem Biophys Res Commun. 200:1994;1598-1603.
39. Van Gool W, Kuiper M, Walstra G, Wolters E, Bolhuis P. Concentration of amyloid β protein in cerebro-spinal fluid of patients with Alzheimer's disease. Ann Neurol. 37:1995;277-279.